Improved conditional expression systems resulting in physiological level of HNF4 expression confirm HNF4 induced apoptosis in the pancreatic -cell line INS-1

BMC Research Notes

Volumn 2, Issue , 2009, Pages

  Senkel, Sabine ^a   Waldner, Christoph ^a   Ryffel, Gerhart ^a   Thomas, Heike ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA;

EID: 77049113060     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-2-210     Document Type: Article

References (23)

1. A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Banaszynski LA Chen LC Maynard-Smith LA Ooi AG, Wandless TJ., Cell 2006 126 995 1004 10.1016/j.cell.2006.07.025 16959577
2. Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Asfari M Janjic D, Meda P Li G, Halban PA Wollheim CB, Endocrinology 1992 130 167 178 10.1210/en.130.1.167 1370150
3. Pattern of genes influenced by conditional expression of the transcription factors HNF6, HNF4alpha and HNF1beta in a pancreatic beta-cell line. Thomas H Senkel S, Erdmann S Arndt T, Turan G Klein-Hitpass L., et al. Nucleic Acids Res 2004 32 150 10.1093/nar/gnh144 15520459
4. Conditional expression of hepatocyte nuclear factor-1beta, the maturity-onset diabetes of the young-5 gene product, influences the viability and functional competence of pancreatic beta-cells. Welters HJ Senkel S, Klein-Hitpass L Erdmann S, Thomas H Harries LW., et al. J Endocrinol 2006 190 171 181 10.1677/joe.1.06768 16837621
5. Tissue-specific transcription factor HNF4alpha inhibits cell proliferation and induces apoptosis in the pancreatic INS-1 beta-cell line. Erdmann S Senkel S, Arndt T Lucas B, Lausen J Klein-Hitpass L., et al. Biol Chem 2007 388 91 106 10.1515/BC.2007.011 17214554
6. The diabetic phenotype in HNF4A mutation carriers is moderated by the expression of HNF4A isoforms from the P1 promoter during fetal development. Harries LW Locke JM, Shields B Hanley NA, Hanley KP Steele A., et al. Diabetes 2008 57 1745 1752 10.2337/db07-1742 18356407
7. A distant upstream promoter of the HNF-4 gene connects the transcription factors involved in maturity onset diabetes of the young. Thomas H Jaschkowitz K, Bulman M Frayling T, Mitchell SMS Roosen S., et al. Hum Mol Genet 2001 10 2089 2097 10.1093/hmg/10.19.2089 11590126
8. A transcription factor regulatory circuit in differentiated pancreatic cells. Boj SF Parrizas M, Maestro MA Ferrer J, Proc Natl Acad Sci USA 2001 98 14481 14486 10.1073/pnas.241349398 11717395
9. Genetic evidence that HNF-1alpha-dependent transcriptional control of HNF-4alpha is essential for human pancreatic beta cell function. Hansen SK Parrizas M, Jensen ML Pruhova S, Ek J Boj SF., et al. J Clin Invest 2002 110 827 833 12235114
10. Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes. Silander K Mohlke KL, Scott LJ Peck EC, Hollstein P Skol AD., et al. Diabetes 2004 53 1141 1149 10.2337/diabetes.53. 4.1141 15047633
11. Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components. Stinski MF Roehr TJ, J Virol 1985 55 431 441 2991567
12. HNF4alpha reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma. Lucas B Grigo K, Erdmann S Lausen J, Klein-Hitpass L Ryffel GU, Oncogene 2005 24 6418 6431 16007190
13. An FKBP destabilization domain modulates protein levels in Plasmodium falciparum. Armstrong CM Goldberg DE, Nat Methods 2007 4 1007 1009 10.1038/nmeth1132 17994030
14. Rapid control of protein level in the apicomplexan Toxoplasma gondii. Herm-Gotz A gop-Nersesian C, Munter S Grimley JS, Wandless TJ Frischknecht F., et al. Nat Methods 2007 4 1003 1005 10.1038/nmeth1134 17994029
15. Conditional protein stabilization via the small molecules Shld-1 and rapamycin increases the signal-to-noise ratio with tet-inducible gene expression. Almogy G Nolan GP, Biotechniques 2009 46 44 50 10.2144/000113030 19301621
16. RhoA induces expression of inflammatory cytokine in adipocytes. Nakayama Y Komuro R, Yamamoto A Miyata Y, Tanaka M Matsuda M., et al. Biochem Biophys Res Commun 2009 379 288 292 10.1016/j.bbrc.2008.12.040 19101507
17. Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87. Grassi G Maccaroni P, Meyer R Kaiser H, D'Ambrosio E Pascale E., et al. Carcinogenesis 2003 24 1625 1635 10.1093/carcin/bgg118 12869421
18. Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus. Teschendorf C Warrington KH Jr, Siemann DW Muzyczka N, Anticancer Res 2002 22 3325 3330 12530082
19. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter. Gill DR Smyth SE, Goddard CA Pringle IA, Higgins CF Colledge WH., et al. Gene Ther 2001 8 1539 1546 10.1038/sj.gt.3301561 11704814
20. Comparison of RNAi efficiency mediated by tetracycline-responsive H1 and U6 promoter variants in mammalian cell lines. Henriksen JR Lokke C, Hammero M Geerts D, Versteeg R Flaegstad T., et al. Nucleic Acids Res 2007 35 67 10.1093/nar/gkm193 17426119
21. Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors. Lazarevich NL Cheremnova OA, Varga EV Ovchinnikov DA, Kudrjavtseva EI Morozova OV., et al. Hepatology 2004 39 1038 1047 10.1002/hep.20155 15057908
22. Activation of p21CIP1/WAF1 gene expression and inhibition of cell proliferation by overexpression of hepatocyte nuclear factor-4alpha. Chiba H Itoh T, Satohisa S Sakai N, Noguchi H Osanai M., et al. Exp Cell Res 2005 302 11 21 10.1016/j.yexcr.2004.08.014 15541721
23. Cell lines derived from pancreatic islets. Hohmeier HE Newgard CB, Mol Cell Endocrinol 2004 228 121 128 10.1016/j.mce.2004.04.017 15541576